These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12001038)
1. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. Buckingham SC; Jafri HS; Bush AJ; Carubelli CM; Sheeran P; Hardy RD; Ottolini MG; Ramilo O; DeVincenzo JP J Infect Dis; 2002 May; 185(9):1222-8. PubMed ID: 12001038 [TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Somers CC; Ahmad N; Mejias A; Buckingham SC; Carubelli C; Katz K; Leos N; Gomez AM; DeVincenzo JP; Ramilo O; Jafri HS Pediatr Allergy Immunol; 2009 Aug; 20(5):477-85. PubMed ID: 19397752 [TBL] [Abstract][Full Text] [Related]
3. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. van Woensel JB; Vyas H; Crit Care Med; 2011 Jul; 39(7):1779-83. PubMed ID: 21460709 [TBL] [Abstract][Full Text] [Related]
5. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Kneyber MC; van Woensel JB; Uijtendaal E; Uiterwaal CS; Kimpen JL; Pediatr Pulmonol; 2008 Feb; 43(2):142-9. PubMed ID: 18085694 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus load predicts disease severity in previously healthy infants. DeVincenzo JP; El Saleeby CM; Bush AJ J Infect Dis; 2005 Jun; 191(11):1861-8. PubMed ID: 15871119 [TBL] [Abstract][Full Text] [Related]
7. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Wright PF; Gruber WC; Peters M; Reed G; Zhu Y; Robinson F; Coleman-Dockery S; Graham BS J Infect Dis; 2002 Apr; 185(8):1011-8. PubMed ID: 11930309 [TBL] [Abstract][Full Text] [Related]
8. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness. Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP; Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. Smith DW; Frankel LR; Mathers LH; Tang AT; Ariagno RL; Prober CG N Engl J Med; 1991 Jul; 325(1):24-9. PubMed ID: 1904551 [TBL] [Abstract][Full Text] [Related]
10. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934 [TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185 [TBL] [Abstract][Full Text] [Related]
16. [Prednisolone treatment of respiratory syncytial virus infection. A randomized, controlled trial of 147 children]. Bülow SL; Nir M; Levin EF; Friis B; Thomsen LL; Nielsen JE; Holm JC; Pedersen TM; Bonde-Hansen MB; Nielsen HE Ugeskr Laeger; 2000 Nov; 162(47):6404-8. PubMed ID: 11116451 [TBL] [Abstract][Full Text] [Related]
17. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Devincenzo JP Pediatr Res; 2004 Dec; 56(6):914-7. PubMed ID: 15470202 [TBL] [Abstract][Full Text] [Related]
18. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus. Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606 [TBL] [Abstract][Full Text] [Related]
19. Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants. Buckingham SC; Bush AJ; Devincenzo JP Pediatr Infect Dis J; 2000 Feb; 19(2):113-7. PubMed ID: 10693996 [TBL] [Abstract][Full Text] [Related]
20. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]